戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 esponsible for type I, type II, and type III tyrosinemia.
2 ish worms as a model for the study of type I tyrosinemia.
3 cer-prone metabolic liver disease hereditary tyrosinemia.
4 umarylacetoacetate hydrolase and manifesting tyrosinemia.
5 on in the Fah(-/-) mouse model of hereditary tyrosinemia.
6  mouse model of the human disease hereditary tyrosinemia.
7 ccinylacetone (SA), a marker for hepatorenal tyrosinemia.
8 lohexanedione (NTBC) is used to treat type I tyrosinemia, a rare but fatal defect in tyrosine catabol
9  approved for use in the treatment of type I tyrosinemia and as such has an extensive history of use
10 trategy to a mouse model of human hereditary tyrosinemia and show that the treatment generated fumary
11  cystic fibrosis, fulminant hepatic failure, tyrosinemia, and chronic rejection.
12 protected from the liver and renal damage of tyrosinemia as hypothesized.
13 all mice that became completely resistant to tyrosinemia-induced hepatic injury.
14                                              Tyrosinemia is a severe childhood disease that affects t
15 wed it to become a curative agent for type I tyrosinemia (T1T) and to enter clinical trials for alkap
16 ification of two metabolic diseases (PKU and tyrosinemia) through blood analysis with minimal sample
17                                   Hereditary tyrosinemia type 1 (HT1) is a severe autosomal recessive
18                                   Hereditary tyrosinemia type 1 (HT1) is an autosomal recessive disea
19               The murine model of hereditary tyrosinemia type 1 (HT1) was used to analyze the relatio
20                     Patients with hereditary tyrosinemia type 1 have a deficiency of fumarylacetoacet
21                                              Tyrosinemia type 1 is caused by deficiency of fumarylace
22 hich is FDA approved for treating hereditary tyrosinemia type 1, elevates plasma tyrosine levels, and
23                                   Hereditary tyrosinemia type I (HT1) results in hepatic failure, cir
24 using the fatal metabolic disease hereditary tyrosinemia type I (HT1).
25 ncy with clinical similarities to hereditary tyrosinemia type I (pseudotyrosinemia).
26 the human metabolic liver disease hereditary tyrosinemia type I and a stringent in vivo model for hep
27                                   Hereditary tyrosinemia type I and alkaptonuria are disorders of tyr
28 se model of the metabolic disease hereditary tyrosinemia type I was used to test whether targeted AAV
29 poson system in the treatment of hemophilia, tyrosinemia type I, junctional epidermolysis bullosa and
30 ls in the FAH(-/-) mouse, an animal model of tyrosinemia type I, rescued the mouse and restored the b
31 ah(-/-)), a model of the human liver disease tyrosinemia type I.
32 atients with the inborn errors of metabolism tyrosinemia type II, argininosuccinic aciduria, homocyst
33           The most severe of these is type I tyrosinemia, which is caused by mutations affecting the

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。